Laura Chico
Stock Analyst at Wedbush
(4.80)
# 522
Out of 4,629 analysts
627
Total ratings
54.7%
Success rate
15.7%
Average return
Main Sectors:
Stocks Rated by Laura Chico
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BCRX BioCryst Pharmaceuticals | Maintained: Buy | $21 → $20 | $9.38 | +113.22% | 17 | Aug 6, 2026 | |
| TVTX Travere Therapeutics | Maintained: Buy | $61 → $75 | $61.32 | +22.31% | 35 | Aug 6, 2026 | |
| VRDN Viridian Therapeutics | Maintained: Buy | $43 → $41 | $23.59 | +73.80% | 74 | Aug 6, 2026 | |
| RARE Ultragenyx Pharmaceutical | Maintained: Hold | $30 | $25.91 | +15.79% | 55 | Aug 5, 2026 | |
| LRMR Larimar Therapeutics | Maintained: Buy | $12 → $11 | $4.16 | +164.42% | 9 | Aug 5, 2026 | |
| DNTH Dianthus Therapeutics | Maintained: Buy | $105 → $122 | $108.92 | +12.01% | 16 | Aug 5, 2026 | |
| NBIX Neurocrine Biosciences | Maintained: Buy | $185 → $194 | $163.41 | +18.72% | 25 | Aug 3, 2026 | |
| BIIB Biogen | Maintained: Hold | $201 → $215 | $207.94 | +3.40% | 69 | Jul 31, 2026 | |
| GOSS Gossamer Bio | Maintained: Hold | $1 | $0.178 | +461.80% | 7 | Jul 29, 2026 | |
| ARDX Ardelyx | Maintained: Buy | $19 | $4.00 | +375.00% | 20 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $23 → $26 | $24.83 | +4.71% | 27 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $43 | $32.89 | +30.74% | 11 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $21.96 | - | 11 | Jul 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $14.00 | - | 6 | Jul 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $52 | $43.52 | +19.49% | 23 | Jun 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $166 → $162 | $360.76 | -55.09% | 24 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $17 → $16 | $8.39 | +90.70% | 8 | May 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $53 | $51.04 | +3.84% | 3 | May 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $21 → $24 | $28.67 | -16.29% | 10 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $7 | $2.63 | +166.16% | 12 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $42 | $34.91 | +20.31% | 8 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5 → $4 | $2.85 | +40.35% | 13 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $58 → $48 | $28.65 | +67.54% | 6 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 | $17.94 | +122.97% | 3 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $63 | $63.36 | -0.57% | 19 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $38 | $32.71 | +16.17% | 15 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $8 → $7 | $3.27 | n/a | 10 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $13 → $11 | $16.16 | n/a | 4 | Apr 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $5 | $13.99 | n/a | 8 | Mar 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $22 → $5 | $6.56 | n/a | 5 | Aug 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $23 | $4.40 | n/a | 4 | Feb 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $3 → $45 | $0.9167 | n/a | 5 | Aug 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $63.81 | n/a | 15 | Jan 2, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $496.07 | n/a | 16 | Jan 2, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $14.30 | n/a | 10 | Sep 12, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $1.49 | n/a | 4 | Aug 13, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $784.36 | n/a | 16 | Aug 8, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $24 | $10.17 | n/a | 1 | Jan 18, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $0.468 | n/a | 1 | Jan 4, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $56.42 | n/a | 1 | Dec 7, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $30 | $1.87 | n/a | 1 | Jun 30, 2017 |
BioCryst Pharmaceuticals
Aug 6, 2026
Maintained: Buy
Price Target: $21 → $20
Current: $9.38
Upside: +113.22%
Travere Therapeutics
Aug 6, 2026
Maintained: Buy
Price Target: $61 → $75
Current: $61.32
Upside: +22.31%
Viridian Therapeutics
Aug 6, 2026
Maintained: Buy
Price Target: $43 → $41
Current: $23.59
Upside: +73.80%
Ultragenyx Pharmaceutical
Aug 5, 2026
Maintained: Hold
Price Target: $30
Current: $25.91
Upside: +15.79%
Larimar Therapeutics
Aug 5, 2026
Maintained: Buy
Price Target: $12 → $11
Current: $4.16
Upside: +164.42%
Dianthus Therapeutics
Aug 5, 2026
Maintained: Buy
Price Target: $105 → $122
Current: $108.92
Upside: +12.01%
Neurocrine Biosciences
Aug 3, 2026
Maintained: Buy
Price Target: $185 → $194
Current: $163.41
Upside: +18.72%
Biogen
Jul 31, 2026
Maintained: Hold
Price Target: $201 → $215
Current: $207.94
Upside: +3.40%
Gossamer Bio
Jul 29, 2026
Maintained: Hold
Price Target: $1
Current: $0.178
Upside: +461.80%
Ardelyx
Jul 13, 2026
Maintained: Buy
Price Target: $19
Current: $4.00
Upside: +375.00%
Jul 13, 2026
Maintained: Buy
Price Target: $23 → $26
Current: $24.83
Upside: +4.71%
Jul 13, 2026
Maintained: Hold
Price Target: $43
Current: $32.89
Upside: +30.74%
Jul 10, 2026
Maintained: Buy
Price Target: n/a
Current: $21.96
Upside: -
Jul 10, 2026
Maintained: Buy
Price Target: n/a
Current: $14.00
Upside: -
Jun 17, 2026
Maintained: Buy
Price Target: $52
Current: $43.52
Upside: +19.49%
Jun 2, 2026
Maintained: Sell
Price Target: $166 → $162
Current: $360.76
Upside: -55.09%
May 18, 2026
Maintained: Buy
Price Target: $17 → $16
Current: $8.39
Upside: +90.70%
May 18, 2026
Maintained: Buy
Price Target: $53
Current: $51.04
Upside: +3.84%
May 14, 2026
Maintained: Hold
Price Target: $21 → $24
Current: $28.67
Upside: -16.29%
May 13, 2026
Maintained: Buy
Price Target: $7
Current: $2.63
Upside: +166.16%
May 13, 2026
Maintained: Buy
Price Target: $42
Current: $34.91
Upside: +20.31%
May 13, 2026
Maintained: Buy
Price Target: $5 → $4
Current: $2.85
Upside: +40.35%
May 13, 2026
Maintained: Buy
Price Target: $58 → $48
Current: $28.65
Upside: +67.54%
May 12, 2026
Reiterated: Buy
Price Target: $40
Current: $17.94
Upside: +122.97%
May 8, 2026
Maintained: Buy
Price Target: $63
Current: $63.36
Upside: -0.57%
May 8, 2026
Maintained: Buy
Price Target: $38
Current: $32.71
Upside: +16.17%
Aug 7, 2024
Maintained: Hold
Price Target: $8 → $7
Current: $3.27
Upside: n/a
Apr 11, 2024
Maintained: Buy
Price Target: $13 → $11
Current: $16.16
Upside: n/a
Mar 20, 2024
Maintained: Hold
Price Target: $5
Current: $13.99
Upside: n/a
Aug 12, 2022
Maintained: Buy
Price Target: $22 → $5
Current: $6.56
Upside: n/a
Feb 11, 2022
Maintained: Buy
Price Target: $23
Current: $4.40
Upside: n/a
Aug 11, 2020
Maintained: Hold
Price Target: $3 → $45
Current: $0.9167
Upside: n/a
Jan 2, 2019
Downgraded: Hold
Price Target: n/a
Current: $63.81
Upside: n/a
Jan 2, 2019
Downgraded: Hold
Price Target: n/a
Current: $496.07
Upside: n/a
Sep 12, 2018
Downgraded: Hold
Price Target: n/a
Current: $14.30
Upside: n/a
Aug 13, 2018
Maintained: Hold
Price Target: n/a
Current: $1.49
Upside: n/a
Aug 8, 2018
Maintained: Hold
Price Target: n/a
Current: $784.36
Upside: n/a
Jan 18, 2018
Initiated Coverage: Buy
Price Target: $24
Current: $10.17
Upside: n/a
Jan 4, 2018
Reiterated: Hold
Price Target: n/a
Current: $0.468
Upside: n/a
Dec 7, 2017
Reiterated: Buy
Price Target: n/a
Current: $56.42
Upside: n/a
Jun 30, 2017
Maintained: Buy
Price Target: $30
Current: $1.87
Upside: n/a